Satyam, S.M.; Bairy, L.K.; Rehman, A.; Nair, A.A.; Farook, M.; Binu, N.N.; Khan, S.; Yehya, M.; Khan, M.M.
Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study. Sci 2025, 7, 59.
https://doi.org/10.3390/sci7020059
AMA Style
Satyam SM, Bairy LK, Rehman A, Nair AA, Farook M, Binu NN, Khan S, Yehya M, Khan MM.
Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study. Sci. 2025; 7(2):59.
https://doi.org/10.3390/sci7020059
Chicago/Turabian Style
Satyam, Shakta Mani, Laxminarayana Kurady Bairy, Abdul Rehman, Anuradha Asokan Nair, Mohamed Farook, Nirmal Nachiketh Binu, Sofiya Khan, Mohamed Yehya, and Mohammed Moin Khan.
2025. "Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study" Sci 7, no. 2: 59.
https://doi.org/10.3390/sci7020059
APA Style
Satyam, S. M., Bairy, L. K., Rehman, A., Nair, A. A., Farook, M., Binu, N. N., Khan, S., Yehya, M., & Khan, M. M.
(2025). Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study. Sci, 7(2), 59.
https://doi.org/10.3390/sci7020059